ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
ALTE15N2: LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
Protocol ID
ALTE15N2
Condition/s
Recurrent Neuroblastoma
Diagnosis Stage
Relapse/refractory
Location
WA, NZ
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
External Registry ≫
Trial Status
Closed to Recruitment
Sites
Perth Children's Hospital
Starship Hospital
Study Type
Late Effects
Phase
Not applicable
Age Eligibility
5 Years to 50 Years
International registry ID's
NCT03057626
Back to Registry
Study Title ALTE15N2: LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
Protocol ID ALTE15N2
Disease (Sub Disease) Recurrent Neuroblastoma
Diagnosis Stage Relapse/refractory
Location WA / NZ
Sponsor Children's Oncology Group
Collaborators National Cancer Institute (NCI)
Links https://clinicaltrials.gov/ct2/show/NCT03057626
Trial Status Closed to Recruitment
Trial Open Date 05/06/2017
Sites Perth Children's Hospital / Starship Hospital
Study Type Late Effects
Phase Not applicable
Age Eligibility 5 Years to 50 Years
International registry ID's NCT03057626

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi. 

We are committed to creating a safe and welcoming environment that embraces all backgrounds, cultures, sexualities, genders and abilities.